Inogen, Inc. Home

Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.

Download Presentation

Latest News

Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Read Press Release View All

Inogen Appoints Eric Pauls as Vice President of Sales, North America

Inogen Announces Second Quarter 2024 Financial Results

Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024

Latest Presentation

2024-08-06

Company Overview

Download View All

Latest Financial Results

Q2 2024

Quarter Ended Jun 30, 2024

$88.8M Second quarter 2024 revenue of $88.8 million
6.1% Second quarter 2024 revenue grew 6.1% year-over-year
48.1% Second quarter 2024 gross margin of 48.1%

For complete information regarding our financials, see our periodic filings

Annual Reports & Proxy Statements

2023 Annual Report

Inogen 2024 Proxy Statement

Inogen 2024 Annual Meeting of Shareholders

Jun 5, 2024 • 10:00am PDT

Sign up for Email Alerts

Give Me Alerts

Stock Information

Inogen, Inc.

View Presentation

About Inogen

Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.

View Company Profile

2023 Revenue Breakdown

2022 Revenue Breakdown

Products

Inogen Rove 6® product image

Inogen Rove 6®

  • 6 pulse dose settings
  • 4.8 pounds
  • Battery life up to 12 hours and 45 minutes
  • Technology clinically validated for 24/7 use
  • Meets FAA requirements
Inogen® Rove 4™ product image

Inogen® Rove 4™

  • 4 pulse dose settings
  • 2.9 pounds with standard battery
  • Battery life up to 5 hours and 45 minutes with extended battery
  • Meets FAA requirements1
  • Technology clinically validated for 24/7 use2

1. Based on Technical Performance Data. Check with your carrier for local regulations.
2. With access to power

Inogen One G4® product image

Inogen One G4®

  • 3 flow settings
  • 2.8 pounds
  • Battery life up to 5 hours
  • Meets FAA requirements
  • Technology clinically validated for 24/7 use
Inogen At Home® product image

Inogen At Home®

  • 5 liters per minute, continuous flow
  • Only 18 pounds
  • Extremely quiet
  • Energy-efficient
  • Only 100W on Flow Setting 2

A Team Built for Success

Our leadership team is focused on strengthening the Inogen brand via expanding awareness of our innovative solutions as well as growing across our consumer and business sales channels.

View Management Team View Board of Directors